Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
ACE D/I polymorphism should not guide clinical decisions; leaves open its value as a genetic research paradigm amid inconsistent evidence.
Harden et al. (1996) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: